Omixon & PIRCHE® collaborate on Epitope Determination with NGS
Omixon & PIRCHE® collaborate on Epitope Determination with NGS

Global molecular diagnostics company Omixon, headquartered in Budapest, and technology company PIRCHE AG, headquartered in Berlin announce a collaboration to deliver the first integrated epitope determination and matching...

Amgen And Los Angeles County Announce Collaboration To Support Life Science Innovation Hub - BioLA
Amgen And Los Angeles County Announce Collaboration To Support Life Science Innovation Hub - BioLA

Amgen (NASDAQ:AMGN) and the County of Los Angeles today announced that Amgen has agreed to become a founding sponsor of BioLA, a newly formed organization focused on advancing a life science innovation hub in Los Angeles...

3D-Printed Blood Vessels: The Tech Just Became Scalable with Mathematica and the Wolfram Language
3D-Printed Blood Vessels: The Tech Just Became Scalable with Mathematica and the Wolfram Language

Researchers at the University of Illinois at Urbana–Champaign and Wolfram Research have developed a novel 3D-printing method called bioprinting that uses isomalt, a type of sugar found in throat lozenges, to generate...

NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018
NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will highlight the...

Thermo Fisher Scientific to Launch Global Customer Solution Centers
Thermo Fisher Scientific to Launch Global Customer Solution Centers

Thermo Fisher Scientific Inc., the world leader in serving science, today announced its intent to open multiple Global Customer Solution Centers. The new Global Customer Solution Centers will focus on meeting and exceeding...

Magnolia Medical Receives Innovative Technology Contract from Vizient, Inc. for Steripath Gen2 Initial Specimen Diversion Device
Magnolia Medical Receives Innovative Technology Contract from Vizient, Inc. for Steripath Gen2 Initial Specimen Diversion Device

Magnolia Medical Technologies, Inc. announced today that it has been awarded an Innovative Technology contract with Vizient, Inc., the largest member-driven health care performance improvement company in the country. The...

Dr. Jared Gollob Joins Kymera Therapeutics as Chief Medical Officer
Dr. Jared Gollob Joins Kymera Therapeutics as Chief Medical Officer

Kymera Therapeutics LLC, a biotechnology company pioneering targeted protein degradation as a transformative new approach to creating breakthrough medicines for patients, today announced the appointment of Jared Gollob,...

BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer

BlueRock Therapeutics, LP, an engineered cell therapy company focused on leveraging its novel Cell+Gene platform to develop regenerative medicines for intractable diseases, today announced the appointment of Shane Kovacs...

Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-8201 in Combination with KEYTRUDA® (pembrolizumab) in HER2 Expressing Breast and HER2 Expressing or HER2 Mutant Lung Cancers
Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-8201 in Combination with KEYTRUDA® (pembrolizumab) in HER2 Expressing Breast and HER2 Expressing or HER2 Mutant Lung Cancers

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A., known as...

PolarityTE to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference
PolarityTE to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference

PolarityTE, Inc. (Nasdaq: PTE), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue...

CytoSorb® Assigned Dedicated Procedure Code in Switzerland
CytoSorb® Assigned Dedicated Procedure Code in Switzerland

CytoSorbents Corporation (NASDAQ:CTSO) a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world,...

Paragon Genomics Launches ParagonDesigner™ Online Tool that MAKES IT Easy TO Design Custom CleanPlex® NGS Assays
Paragon Genomics Launches ParagonDesigner™ Online Tool that MAKES IT Easy TO Design Custom CleanPlex® NGS Assays

Paragon Genomics, Inc. today announced the launch of ParagonDesigner™, its web-based tool that enables rapid design of CleanPlex® Custom NGS Panels. The online portal features a streamlined, user-friendly interface that...

Merrimack Receives $5 Million Milestone Payment from Shire
Merrimack Receives $5 Million Milestone Payment from Shire

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced that it has received a $5 million milestone payment from Shire, triggered by the sale...

Flow Cytometry Market is Expected to Fetch Revenue Worth US$8100 mn by 2025; Demand for Treating Fatal Diseases Bolsters Growth Globally - TMR
Flow Cytometry Market is Expected to Fetch Revenue Worth US$8100 mn by 2025; Demand for Treating Fatal Diseases Bolsters Growth Globally - TMR

According to the analysts, the flow cytometry market is anticipated to expand at a robust CAGR of 11.0% during the assessed period from 2017 - 2025. The market was valued at US$3702mn in 2016, and with such a steady CAGR,...

Intec Pharma to Participate at Upcoming Investment Conferences
Intec Pharma to Participate at Upcoming Investment Conferences

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences.

Mylan and Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio®, Biosimilar Adalimumab
Mylan and Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio®, Biosimilar Adalimumab

Mylan N.V. (NASDAQ: MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for Hulio® (Product Code: FKB327), a biosimilar to AbbVie's...

AGC Biologics Adds Mammalian Production Capacity in Japan
AGC Biologics Adds Mammalian Production Capacity in Japan

AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that as part of its ongoing program to expand its production capacities globally, it will establish a new...

Providence Medical Technology Secures $25 Million In Equity Financing
Providence Medical Technology Secures $25 Million In Equity Financing

Providence Medical Technology, Inc., an innovator in tissue-sparing surgical equipment and implants for cervical spine fusion surgery, today announced the closing of $25 million in new equity financing. Revelation Partners...

Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare
Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare

Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report "Moving data to the heart of health systems: Increasing vital technology adoption to make...

Puritan Set to Receive Two New U.S. Patents for their High-Performance Flocked Swabs
Puritan Set to Receive Two New U.S. Patents for their High-Performance Flocked Swabs

Puritan Medical Products, North America's largest manufacturer of specimen collection devices is set to receive two new U.S. patents for their high-performance flocked swabs, the single-use medical device manufacturer...

Lonza Expands Ibex™ Solutions to Offer Complete Product Lifecycle Management in One Location
Lonza Expands Ibex™ Solutions to Offer Complete Product Lifecycle Management in One Location

Lonza announces the addition of two new Ibex™ Solutions offerings to Lonza's 100,000 m2 (1.1 million ft2) biopark in Visp (CH). In July 2017 Ibex™ Dedicate, a modular, technology-agnostic biomanufacturing concept, was...

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment for Patients with NSCLC at Annual Meeting of the Chinese Society of Clinical Oncology
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment for Patients with NSCLC at Annual Meeting of the Chinese Society of Clinical Oncology

Innovent Biologics (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical trial data on cohort D of sintilimab clinical studies at the...

Viking Therapeutics Announces Proposed Public Offering of Common Stock
Viking Therapeutics Announces Proposed Public Offering of Common Stock

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it intends to offer...

Antibody Discovery Services and Platforms Market, 2028 - Current Market Landscape and Future Outlook of Companies
Antibody Discovery Services and Platforms Market, 2028 - Current Market Landscape and Future Outlook of Companies

The "Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028" report has been added to ResearchAndMarkets.com's offering. The Antibody Discovery: Services and Platforms (2nd Edition),...

Global Rapid Microbiology Testing Market 2018-2023: Major Players Profiled Include bioMrieux, Abbott Laboratories, Danaher, and Becton, Dickinson and Co
Global Rapid Microbiology Testing Market 2018-2023: Major Players Profiled Include bioMrieux, Abbott Laboratories, Danaher, and Becton, Dickinson and Co

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, Sept 19, 2018 /PRNewswire/ -- The "Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Ident...

Rhode Island Headlines 

Massachusetts Headlines 

National